PTCT (PTC Therapeutics, Inc.) Stock Analysis - Hedge Fund Holdings

PTC Therapeutics, Inc. (PTCT) is a publicly traded Healthcare sector company. As of May 21, 2026, PTCT trades at $71.52 with a market cap of $5.82B and a P/E ratio of -28.67. PTCT moved +0.78% today. Year to date, PTCT is -7.48%; over the trailing twelve months it is +50.47%. Its 52-week range spans $34.57 to $87.50. Analyst consensus is strong buy with an average price target of $93.10. Rallies surfaces PTCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns PTCT stock?

Hedge funds tracked by Rallies that own PTCT include Panagora Asset, Centerbook Partners, Orbimed Advisors, Eisler Capital, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for PTC Therapeutics, Inc..

PTCT Key Metrics

Key financial metrics for PTCT
MetricValue
Price$71.52
Market Cap$5.82B
P/E Ratio-28.67
EPS$-2.48
Dividend Yield0.00%
52-Week High$87.50
52-Week Low$34.57
Volume334
Avg Volume0
Revenue (TTM)$827.11M
Net Income$-186.73M
Gross Margin0.00%

Top Hedge Funds Holding PTCT

  • Panagora Asset holds 351.37K shares of PTCT, changed -2.35% as of Mar 31, 2026.
  • Centerbook Partners holds 56.81K shares of PTCT, changed +0.00% as of Mar 31, 2026.
  • Orbimed Advisors holds 49.10K shares of PTCT, changed +111.64% as of Mar 31, 2026.
  • Eisler Capital holds 23.78K shares of PTCT, changed -2.24% as of Jun 30, 2024.
  • Bridgewater Associates holds 16.23K shares of PTCT, changed +35.94% as of Dec 31, 2025.

Latest PTCT News

Recent PTCT Insider Trades

  • Klein Matthew B. sold 679 (~$49.61K) on May 14, 2026.
  • Klein Matthew B. sold 7.22K (~$527.71K) on May 14, 2026.
  • Klein Matthew B. sold 2.10K (~$153.47K) on May 14, 2026.

PTCT Analyst Consensus

13 analysts cover PTCT: 0 strong buy, 10 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $93.10.

Common questions about PTCT

Who owns PTCT stock?
Hedge funds tracked by Rallies that own PTCT include Panagora Asset, Centerbook Partners, Orbimed Advisors, Eisler Capital, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for PTC Therapeutics, Inc..
Does Rallies show 13F holders for PTCT?
Yes. Rallies tracks hedge fund and 13F ownership data for PTCT, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PTCT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PTCT. It does not provide personalized investment advice.
PTCT

PTCT